Synopsys, Inc.
SNPSNasdaqFull coverage
Price
Loading your watchlists
Income statement
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions · shares in millions · per-share in USD
| Line | Trend | FY 2025Ended Oct 31, | FY 2024Ended Oct 31, | FY 2023Ended Oct 31, | FY 2022Ended Oct 31, | FY 2021Ended Oct 31, | FY 2020Ended Oct 31, | FY 2019Ended Oct 31, | FY 2018Ended Oct 31, | FY 2017Ended Oct 31, | FY 2016Ended Oct 31, | FY 2015Ended Oct 31, | FY 2014Ended Oct 31, | FY 2013Ended Oct 31, | FY 2012Ended Oct 31, | FY 2011Ended Oct 31, | FY 2010Ended Oct 31, | FY 2009Ended Oct 31, | FY 2008Ended Oct 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Cost of revenue | |||||||||||||||||||
| Gross profit | |||||||||||||||||||
| Provision for credit losses | |||||||||||||||||||
| Provision for loan losses | |||||||||||||||||||
| Research and development | |||||||||||||||||||
| Selling, general and administrative | |||||||||||||||||||
| Selling and marketing | |||||||||||||||||||
| General and administrative | |||||||||||||||||||
| Restructuring charges | |||||||||||||||||||
| Goodwill impairment | |||||||||||||||||||
| Operating expenses | |||||||||||||||||||
| Total costs and expenses | |||||||||||||||||||
| Operating income | |||||||||||||||||||
| Interest expense | |||||||||||||||||||
| Interest income | |||||||||||||||||||
| Non-operating income (expense), net | |||||||||||||||||||
| Other non-operating income (expense) | |||||||||||||||||||
| Gains (losses) on investments | |||||||||||||||||||
| Income before taxes | |||||||||||||||||||
| Income tax | |||||||||||||||||||
| Income from continuing operations | |||||||||||||||||||
| Income from continuing operations, including non-controlling interests | |||||||||||||||||||
| Income from discontinued operations | |||||||||||||||||||
| Discontinued operations attributable to the company | |||||||||||||||||||
| Net income including non-controlling interests | |||||||||||||||||||
| Net income attributable to non-controlling interests | |||||||||||||||||||
| Net income | |||||||||||||||||||
| Basic EPS | |||||||||||||||||||
| Diluted EPS | |||||||||||||||||||
| Weighted average shares (basic) | |||||||||||||||||||
| Weighted average shares (diluted) | |||||||||||||||||||
| Other comprehensive income, including non-controlling interests | |||||||||||||||||||
| Foreign currency translation | |||||||||||||||||||
| Unrealized gains (losses) on available-for-sale securities | |||||||||||||||||||
| Cash flow hedges | |||||||||||||||||||
| Comprehensive income, including non-controlling interests | |||||||||||||||||||
| Comprehensive income attributable to non-controlling interests | |||||||||||||||||||
| Comprehensive income | |||||||||||||||||||
| Lease cost | |||||||||||||||||||
| Operating lease cost | |||||||||||||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years | 10 years |
|---|---|---|---|---|---|
| Revenue | |||||
| Gross profit | |||||
| Diluted EPS | |||||
| Free cash flow | |||||
| Diluted share count |
Margins
An item moved a margin in this period
| Margin | TTM Q4 2021Ended Oct 31, | TTM Q1 2022Ended Jan 31, | TTM Q2 2022Ended Apr 30, | TTM Q3 2022Ended Jul 31, | TTM Q4 2022Ended Oct 31, | TTM Q1 2023Ended Jan 31, | TTM Q2 2023Ended Apr 30, | TTM Q3 2023Ended Jul 31, | TTM Q4 2023Ended Oct 31, | TTM Q1 2024Ended Jan 31, | TTM Q2 2024Ended Apr 30, | TTM Q3 2024Ended Jul 31, | TTM Q4 2024Ended Oct 31, | TTM Q1 2025Ended Jan 31, | TTM Q2 2025Ended Apr 30, | TTM Q3 2025Ended Jul 31, | TTM Q4 2025Ended Oct 31, | TTM Q1 2026Ended Jan 31, | TTM Q2 2026Ended Apr 30, | TTM Q3 2026Ended Jul 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin | ||||||||||||||||||||
| FCF margin |